Lucid Drone Technologies Taps T-Mobile to Power Commercial Cleaning Drones
25.4.2022 16:23:00 EEST | Business Wire | Press release
Today, T-Mobile (NASDAQ: TMUS) announced that Lucid Drone Technologies has chosen the Un-carrier to be the exclusive provider of IoT connectivity and management for their fleet of industrial spraying drones. Together, Lucid Drone Technologies and T-Mobile are collaborating to put maintenance teams and exterior cleaning companies out of harm’s way using drone technology for high-risk facilities maintenance work like exterior soft-wash cleaning and high-rise window washing. The companies also plan to leverage T-Mobile's industry-leading 5G network in the future to fly drones beyond line-of-sight and power more data-intensive capabilities like video streaming.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220424005109/en/
Lucid Drone Technologies has chosen T-Mobile as the exclusive provider of IoT connectivity and management for their growing fleet of industrial spraying drones that provide commercial cleaning services.
A game changer for safety of maintenance teams
Commercial property management firms and developers make significant investments to keep maintenance teams safe. Expensive liability insurance premiums and equipment fees have facilities leaders looking for new and cost-effective solutions. Enter industrial spraying drone pioneer Lucid Drone Technologies and the Un-carrier to deliver a game changer — drones equipped to clean exterior building surfaces and windows.
The next generation of Lucid Drone Technologies industrial spraying drones, powered by T-Mobile for Business, can perform exterior washing for commercial building surfaces and windows, including outdoor stadiums and arenas, hotels, and university structures. That means maintenance teams can steer clear of some high-risk tasks, keeping them safer and focused on other mission critical work.
IoT driving the future of industrial spraying drone technology
T-Mobile’s network powers critical capabilities for Lucid Drone Technologies industrial spraying drones such as real-time sharing of flight data, battery utilization information, hardware diagnostics, and delivery of firmware and software updates. Additionally, T-Mobile Control Center will give Lucid Drone Technologies the ability to view and manage the connectivity of their industrial spraying drones. With the automation and provisioning capabilities of T-Mobile’s IoT platform, Lucid Drone Technologies can easily accelerate deployment of their growing fleet. Lucid Drone Technologies will have near real-time visibility to all their industrial spraying drones with the ability to monitor network conditions and device behavior with T-Mobile Control Center.
Initially, T-Mobile for Business will deliver 4G LTE connectivity to Lucid Drone Technologies industrial spraying drones, providing a reliable connection nationwide. Lucid Drone Technologies expects to utilize the Un-carrier's 5G network in the near future for advanced use cases such as network operations center access, live streaming video and remote piloting. As Americas largest and fastest 5G network, T-Mobile is poised to push IoT to its full potential and catapult adoption — paving the way for new drone applications that rely on low-latency, high-speed data, and real-time location and proximity-based services.
"At Lucid Drone Technologies, we are committed to providing robotic solutions that allow our customers to complete jobs that were once dull, dirty, and dangerous in a safer, faster, and smarter way,” said Andrew Ashur, CEO, Lucid Drone Technologies. “T-Mobile not only allows us to provide our customers with the highest quality of real-time support and connectivity today, but they also have impressive 5G capabilities that allow us to push the frontier limits of responsible robotics."
“Lucid Drone Technologies is a great example of a customer using originality and new technology to solve complicated problems,” said Callie Field, President, T-Mobile Business Group. “It’s not very often that you get to collaborate with these kinds of thinkers, and we’re thrilled to have the opportunity to offer our technology to help bring their vision to life.”
To learn more about Lucid Drone Technologies, visit: www.luciddronetech.com
For more information about IoT from T-Mobile for Business, go to: www.t-mobile.com/business/solutions/iot
Follow T-Mobile’s Official Twitter Newsroom @TMobileNews to stay up to date with the latest company news.
Fastest based on median, overall combined 5G speeds according to analysis by Ookla® of Speedtest Intelligence® data 5G download speeds for Q1 2022. Ookla trademarks used under license and reprinted with permission.
About T-Mobile
T-Mobile U.S. Inc. (NASDAQ: TMUS) is America’s supercharged Un-carrier, delivering an advanced 4G LTE and transformative nationwide 5G network that will offer reliable connectivity for all. T-Mobile’s customers benefit from its unmatched combination of value and quality, unwavering obsession with offering them the best possible service experience and undisputable drive for disruption that creates competition and innovation in wireless and beyond. Based in Bellevue, Wash., T-Mobile provides services through its subsidiaries and operates its flagship brands, T-Mobile, Metro by T-Mobile and Sprint. For more information please visit: https://www.t-mobile.com.
About Lucid Drone Technologies
Lucid Drone Technologies is a Charlotte, NC-based robotics company that currently designs and builds industrial spraying drones for labor-intensive jobs. Lucid Drone Technologies was started in 2018, and set out to provide a Safer, Faster, and Smarter alternative to traditional dull, dirty, and dangerous jobs.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220424005109/en/
Contact information
Media Contacts
T-Mobile US, Inc. Media Relations
MediaRelations@t-mobile.com
Lucid Drone Technologies
John Dry
jdry@luciddronetech.com
Investor Relations Contact
T-Mobile US, Inc.
investor.relations@t-mobile.com
https://investor.t-mobile.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom